首页> 外文期刊>The American Journal of Surgery >Adult refractory hypoxemic acute respiratory distress syndrome treated with extracorporeal membrane oxygenation: The role of a regional referral center
【24h】

Adult refractory hypoxemic acute respiratory distress syndrome treated with extracorporeal membrane oxygenation: The role of a regional referral center

机译:成人难治性低氧血症急性呼吸窘迫综合征的体外膜氧合治疗:区域转诊中心的作用

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The investigators present a series of adults with severe acute respiratory distress syndrome (ARDS) who were treated with extracorporeal membrane oxygenation (ECMO) at a regional referral center. Methods: Patients with refractory hypoxic ARDS received ECMO until they recovered lung function or demonstrated futility. ECMO was initiated at the referring facility if necessary, and aggressive critical care was maintained throughout. Results: ARDS due to multiple etiologies was managed with ECMO in 36 adults. The pre-ECMO ratio of partial pressure of oxygen to fraction of inspired oxygen was 48.3 ± 2.2. Regional facilities referred 89% of these patients, and 69% required ECMO for transport. The mean duration of ECMO was 7.1 ±.9 days for survivors, and the mean post-ECMO ratio of partial pressure of oxygen to fraction of inspired oxygen was 281.2 ± 11. ECMO was successfully weaned in 67% of patients, and 60% survived to discharge. Conclusions: ECMO provides support that prevents ventilator-induced lung injury while the lungs heal. The investigators present a series of 36 adults with refractory hypoxemic ARDS (ratio of partial pressure of oxygen to fraction of inspired oxygen <50) from 17 different facilities who, treated with ECMO at a single referral center, had a 60% survival rate.
机译:背景:研究人员介绍了一系列患有严重急性呼吸窘迫综合征(ARDS)的成年人,他们在区域转诊中心接受了体外膜氧合(ECMO)治疗。方法:难治性低氧ARDS患者接受ECMO治疗,直到他们恢复肺功能或证明无效。如有必要,ECMO会在转诊机构启动,并且始终保持积极的重症监护。结果:使用ECMO对36位成人进行了多种病因致ARDS治疗。 ECMO之前的氧气分压与吸入氧气的比例为48.3±2.2。区域机构转诊了89%的此类患者,而69%的患者需要ECMO进行运输。幸存者的ECMO平均持续时间为7.1±.9天,ECMO后氧分压与吸入氧分率的平均比率为281.2±11。ECMO在67%的患者中成功断奶,60%存活放电。结论:ECMO提供的支持可防止呼吸机诱发的肺部愈合过程中的肺部损伤。研究人员介绍了来自17个不同机构的36名成年人的难治性低氧血症性ARDS(氧气分压与吸入氧气分数的比率<50),这些患者在单个转诊中心接受ECMO治疗,生存率为60%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号